Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advancing the development of tuberculosis therapy

Abstract

Although the development of novel drugs and combination regimens for tuberculosis has accelerated in recent years, the pipeline remains thin and major challenges remain to be addressed in efficiently evaluating newer drugs to improve treatment outcomes, shorten duration of therapy and tackle drug resistance.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. World Health Organization. Global tuberculosis control 2011. WHO website [online], (WHO, Geneva, Switzerland, 2011).

  2. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. WHO website [online], (WHO, Geneva, Switzerland, 2012).

  3. Orenstein, E. W. et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect. Dis. 9, 153–161 (2009).

    Article  Google Scholar 

  4. STOP TB Partnership. Working group on new TB drugs discovery portfolio. New TB Drugs website [online], (2011).

  5. Phillips, P. et al. Innovative trial designs are practical solutions for improving the treatment of tuberculosis. J. Infect. Dis. (in the press).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alimuddin Zumla.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zumla, A., Hafner, R., Lienhardt, C. et al. Advancing the development of tuberculosis therapy. Nat Rev Drug Discov 11, 171–172 (2012). https://doi.org/10.1038/nrd3694

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3694

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research